Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis.

Autor: Bapir, Rawa1,2 Dr.rawa@yahoo.com, Bhatti, Kamran Hassan2,3 kamibhatti92@gmail.com, Eliwa, Ahmed2,4 ahmedeliwafarag@gmail.com, Andrés García-Perdomo, Herney2,5 herney.garcia@correounivalle.edu.co, Gherabi, Nazim2,6 ngherabi@gmail.com, Hennessey, Derek2,7 derek.hennessey@gmail.com, Magri, Vittorio2,8 vittorio.magri@asst-fbf-sacco.it, Mourmouris, Panagiotis2,9 thodoros13@yahoo.com, Ouattara, Adama2,10 adamsouat1@hotmail.com, Perletti, Gianpaolo2,11 Gianpaolo.Perletti@uninsubria.it, Philipraj, Joseph2,12 josephphilipraj@gmail.com, Stamatiou, Konstantinos2,13 stamatiouk@gmail.com, Tolani, Musliu Adetola2,14 adetolatolani@yahoo.com, Tzelves, Lazaros2,9 lazarostzelves@gmail.com, Anker, Stefan D.15 anker@cachexia.de, Trinchieri, Alberto2,16 alberto.trinchieri@gmail.com, Buchholz, Noor2 noor.buchholz@gmail.com
Zdroj: Archives of Italian Urology & Andrology / Archivio Italiano di Urologia Andrologia. 2023, Vol. 95 Issue 2, p112-112L. 18p.
Databáze: Academic Search Ultimate